Point-of-care molecular diagnosis of Mycoplasma pneumoniae including macrolide sensitivity using quenching probe polymerase chain reaction

Macrolides are generally considered to be the drugs of choice for treatment of patients with Mycoplasma pneumoniae infection. However, macrolide-resistant M. pneumoniae has been emerging since about 2000. The Smart Gene.sup.® system (MIZUHO MEDY Co., Ltd., Tosu, Japan) is a novel fully automated sys...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PloS one 2021-10, Vol.16 (10), p.e0258694-e0258694
Hauptverfasser:	Ishiguro, Nobuhisa, Sato, Rikako, Mori, Toshihiko, Tanaka, Hiroshi, Narita, Mitsuo, Nagano, Takashi, Owaku, Masato, Miyajima, Kensuke, Manabe, Atsushi
Format:	Artikel
Sprache:	eng
Schlagworte:	Acids Analysis Antibiotics Antimicrobial agents Asthma Biology and Life Sciences Cartilage Clarithromycin Diagnosis Domains Drug resistance Evaluation Funding Hospitals Infections Infectious diseases Medical diagnosis Medicine and Health Sciences Molecular diagnostic techniques Mutation Mycoplasma pneumoniae Pathogens Patients Pediatrics Pharynx Pneumonia Point mutation Point of care testing Polymerase chain reaction Research and Analysis Methods Respiratory tract Respiratory tract diseases rRNA rRNA 23S Sensitivity University graduates
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!